Chronic prostatitis/Chronic pelvic pain syndrome(CP/CPPS)
Conditions
Interventions
Participant will receive one of two oral doses of NS-580 and/or placebo over a treatment period.
Sponsors
Higashioka Masaya
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Patients with persistent or recurrent pelvic pain or discomfort for a total of at least 3 months out of 6 months up to the date of primary registration 2) Patients with pain or discomfort in the prostate or perineum/pubic region on palpation 3) Patients who answered 'yes' to at least one of the six items in questions 1 and 2 of the National Institutes of Health Chronic Prostate Symptom Score (NIH-CPSI)
Exclusion criteria
Exclusion criteria: 1) Patients diagnosed with urinary tract infection or bacterial prostatitis by the Pre and Post Massage Test (PPMT) method 2) Patients with complications with pelvic pain not attributable to CP/CPPS (e.g. inflammatory bowel disease, irritable bowel syndrome) 3) Patients with complications of diseases around the anus, including inguinal hernia and haemorrhoids, which the principal investigator (sub-investigator) considers to have a potential risk that may interrupt the assessment of efficacy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in total NIH-CPSI score from the baseline to each mesurement time point | — |
Contacts
Public ContactOperations Clinical
Nippon Shinyaku Co., Ltd.
Outcome results
None listed